Operating Profit Margin
since 2005
Paying user area
Try for free
Illumina Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Analysis of Profitability Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Illumina Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Illumina Inc., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Income (loss) from operations1 | ÷ | Revenue1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | = | 100 | × | ÷ | |||
| Dec 29, 2019 | = | 100 | × | ÷ | |||
| Dec 30, 2018 | = | 100 | × | ÷ | |||
| Dec 31, 2017 | = | 100 | × | ÷ | |||
| Jan 1, 2017 | = | 100 | × | ÷ | |||
| Jan 3, 2016 | = | 100 | × | ÷ | |||
| Dec 28, 2014 | = | 100 | × | ÷ | |||
| Dec 29, 2013 | = | 100 | × | ÷ | |||
| Dec 30, 2012 | = | 100 | × | ÷ | |||
| Jan 1, 2012 | = | 100 | × | ÷ | |||
| Jan 2, 2011 | = | 100 | × | ÷ | |||
| Jan 3, 2010 | = | 100 | × | ÷ | |||
| Dec 28, 2008 | = | 100 | × | ÷ | |||
| Dec 30, 2007 | = | 100 | × | ÷ | |||
| Dec 31, 2006 | = | 100 | × | ÷ | |||
| Jan 1, 2006 | = | 100 | × | ÷ |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$ in millions
Comparison to Competitors
Illumina Inc., operating profit margin, long-term trends, comparison to competitors
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Moderna Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | ||||||||
| Dec 29, 2019 | ||||||||
| Dec 30, 2018 | ||||||||
| Dec 31, 2017 | ||||||||
| Jan 1, 2017 | ||||||||
| Jan 3, 2016 | ||||||||
| Dec 28, 2014 | ||||||||
| Dec 29, 2013 | ||||||||
| Dec 30, 2012 | ||||||||
| Jan 1, 2012 | ||||||||
| Jan 2, 2011 | ||||||||
| Jan 3, 2010 | ||||||||
| Dec 28, 2008 | ||||||||
| Dec 30, 2007 | ||||||||
| Dec 31, 2006 | ||||||||
| Jan 1, 2006 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).